Aortic stenosis is a valvular heart disease with varying severity. Narrowed valve openings of the large blood vessel aorta reduce blow flow making the heart pump excessively. Poor prognosis with a fatal mortality rate is observed in severe cases. In-time diagnosis and treatment are of significant importance.
According to publisher’s new survey, global Aortic Stenosis market is projected to reach US$ 10620 million in 2029, increasing from US$ 5398 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aortic Stenosis market research.
Key companies engaged in the Aortic Stenosis industry include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Aortic Stenosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Aortic Stenosis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Aortic Stenosis report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aortic Stenosis Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Transcatheter Aortic Valve Implantation (TAVI)
1.2.3 Surgical Aortic Valve Replacement (SAVR)
1.3 Market by Application
1.3.1 Global Aortic Stenosis Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Congenital Aortic Stenosis
1.3.3 Acquired Aortic Stenosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aortic Stenosis Market Perspective (2018-2029)
2.2 Aortic Stenosis Growth Trends by Region
2.2.1 Global Aortic Stenosis Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Aortic Stenosis Historic Market Size by Region (2018-2023)
2.2.3 Aortic Stenosis Forecasted Market Size by Region (2024-2029)
2.3 Aortic Stenosis Market Dynamics
2.3.1 Aortic Stenosis Industry Trends
2.3.2 Aortic Stenosis Market Drivers
2.3.3 Aortic Stenosis Market Challenges
2.3.4 Aortic Stenosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aortic Stenosis Players by Revenue
3.1.1 Global Top Aortic Stenosis Players by Revenue (2018-2023)
3.1.2 Global Aortic Stenosis Revenue Market Share by Players (2018-2023)
3.2 Global Aortic Stenosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aortic Stenosis Revenue
3.4 Global Aortic Stenosis Market Concentration Ratio
3.4.1 Global Aortic Stenosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aortic Stenosis Revenue in 2022
3.5 Aortic Stenosis Key Players Head office and Area Served
3.6 Key Players Aortic Stenosis Product Solution and Service
3.7 Date of Enter into Aortic Stenosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Aortic Stenosis Breakdown Data by Type
4.1 Global Aortic Stenosis Historic Market Size by Type (2018-2023)
4.2 Global Aortic Stenosis Forecasted Market Size by Type (2024-2029)
5 Aortic Stenosis Breakdown Data by Application
5.1 Global Aortic Stenosis Historic Market Size by Application (2018-2023)
5.2 Global Aortic Stenosis Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Aortic Stenosis Market Size (2018-2029)
6.2 North America Aortic Stenosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Aortic Stenosis Market Size by Country (2018-2023)
6.4 North America Aortic Stenosis Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aortic Stenosis Market Size (2018-2029)
7.2 Europe Aortic Stenosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Aortic Stenosis Market Size by Country (2018-2023)
7.4 Europe Aortic Stenosis Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aortic Stenosis Market Size (2018-2029)
8.2 Asia-Pacific Aortic Stenosis Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Aortic Stenosis Market Size by Region (2018-2023)
8.4 Asia-Pacific Aortic Stenosis Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aortic Stenosis Market Size (2018-2029)
9.2 Latin America Aortic Stenosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Aortic Stenosis Market Size by Country (2018-2023)
9.4 Latin America Aortic Stenosis Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aortic Stenosis Market Size (2018-2029)
10.2 Middle East & Africa Aortic Stenosis Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Aortic Stenosis Market Size by Country (2018-2023)
10.4 Middle East & Africa Aortic Stenosis Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Aortic Stenosis Introduction
11.1.4 Abbott Laboratories Revenue in Aortic Stenosis Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 AstraZeneca Plc.
11.2.1 AstraZeneca Plc. Company Detail
11.2.2 AstraZeneca Plc. Business Overview
11.2.3 AstraZeneca Plc. Aortic Stenosis Introduction
11.2.4 AstraZeneca Plc. Revenue in Aortic Stenosis Business (2018-2023)
11.2.5 AstraZeneca Plc. Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Detail
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Aortic Stenosis Introduction
11.3.4 Boston Scientific Corporation Revenue in Aortic Stenosis Business (2018-2023)
11.3.5 Boston Scientific Corporation Recent Development
11.4 Coroneo
11.4.1 Coroneo Company Detail
11.4.2 Coroneo Business Overview
11.4.3 Coroneo Aortic Stenosis Introduction
11.4.4 Coroneo Revenue in Aortic Stenosis Business (2018-2023)
11.4.5 Coroneo Recent Development
11.5 CryoLife, Inc.
11.5.1 CryoLife, Inc. Company Detail
11.5.2 CryoLife, Inc. Business Overview
11.5.3 CryoLife, Inc. Aortic Stenosis Introduction
11.5.4 CryoLife, Inc. Revenue in Aortic Stenosis Business (2018-2023)
11.5.5 CryoLife, Inc. Recent Development
11.6 Edwards Lifesciences Corporation
11.6.1 Edwards Lifesciences Corporation Company Detail
11.6.2 Edwards Lifesciences Corporation Business Overview
11.6.3 Edwards Lifesciences Corporation Aortic Stenosis Introduction
11.6.4 Edwards Lifesciences Corporation Revenue in Aortic Stenosis Business (2018-2023)
11.6.5 Edwards Lifesciences Corporation Recent Development
11.7 JenaValve Technology, Inc.
11.7.1 JenaValve Technology, Inc. Company Detail
11.7.2 JenaValve Technology, Inc. Business Overview
11.7.3 JenaValve Technology, Inc. Aortic Stenosis Introduction
11.7.4 JenaValve Technology, Inc. Revenue in Aortic Stenosis Business (2018-2023)
11.7.5 JenaValve Technology, Inc. Recent Development
11.8 LifeNet Health
11.8.1 LifeNet Health Company Detail
11.8.2 LifeNet Health Business Overview
11.8.3 LifeNet Health Aortic Stenosis Introduction
11.8.4 LifeNet Health Revenue in Aortic Stenosis Business (2018-2023)
11.8.5 LifeNet Health Recent Development
11.9 LivaNova PLC
11.9.1 LivaNova PLC Company Detail
11.9.2 LivaNova PLC Business Overview
11.9.3 LivaNova PLC Aortic Stenosis Introduction
11.9.4 LivaNova PLC Revenue in Aortic Stenosis Business (2018-2023)
11.9.5 LivaNova PLC Recent Development
11.10 Medtronic Plc
11.10.1 Medtronic Plc Company Detail
11.10.2 Medtronic Plc Business Overview
11.10.3 Medtronic Plc Aortic Stenosis Introduction
11.10.4 Medtronic Plc Revenue in Aortic Stenosis Business (2018-2023)
11.10.5 Medtronic Plc Recent Development
11.11 Meril Life Sciences Pvt. Ltd.
11.11.1 Meril Life Sciences Pvt. Ltd. Company Detail
11.11.2 Meril Life Sciences Pvt. Ltd. Business Overview
11.11.3 Meril Life Sciences Pvt. Ltd. Aortic Stenosis Introduction
11.11.4 Meril Life Sciences Pvt. Ltd. Revenue in Aortic Stenosis Business (2018-2023)
11.11.5 Meril Life Sciences Pvt. Ltd. Recent Development
11.12 Thubrikar Aortic Valve
11.12.1 Thubrikar Aortic Valve Company Detail
11.12.2 Thubrikar Aortic Valve Business Overview
11.12.3 Thubrikar Aortic Valve Aortic Stenosis Introduction
11.12.4 Thubrikar Aortic Valve Revenue in Aortic Stenosis Business (2018-2023)
11.12.5 Thubrikar Aortic Valve Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
*If Applicable.